On the Reasonableness of Porcine Labial Mucosa as a Model for Buccal Mucosal Medication Conveyance Exploration

Received: 02-May-2023, Manuscript No. IJDRT-23-106039; Editor assigned: 04-May-2023, Pre QC No. P-106039; Reviewed: 16-May-2023, QC No. Q-106039; Revised: 22-May-2023, Manuscript No. R-106039; Published: 29-May-2023, DOI: 10.37421/2277-1506.2023.12.400

Introduction

Porcine labial mucosa has been widely used as a model for B. mucosa l drug delivery research due to its anatomical and physiological similarities to human B. mucosa. Here are some considerations on the reasonableness of using porcine labial mucosa as a model for B. mucosa l drug delivery research. The anatomy of porcine labial mucosa closely resembles that of human B. mucosa. It consists of stratified squamous epithelium, connective tissue, blood vessels, and minor salivary glands, similar to the B. mucosa in humans. This similarity in anatomical structure allows for comparative studies and provides insights into drug permeation and absorption through the B. mucosa. Porcine labial mucosa exhibits physiological characteristics that are comparable to human B. mucosa. For example, it has a relatively low permeability to hydrophilic drugs due to the presence of a tight junction barrier, similar to human B. mucosa. Additionally, the enzymatic activity and pH of porcine saliva are similar to those in human saliva, which can affect drug stability and bioavailability. Porcine labial mucosa is readily available from abattoirs or slaughterhouses, making it a cost-effective model for B. mucosa drug delivery research. The large size of the porcine lips allows for easy collection of mucosal tissue, providing an abundant and consistent supply for experimentation [1].

Description

The use of animal models in scientific research raises ethical considerations. However, porcine labial mucosa is often obtained as a byproduct of the meat industry, and its use can be justified when it contributes to advancing scientific knowledge and improving drug delivery systems. Researchers should follow ethical guidelines and obtain appropriate approvals for the use of animal tissues. While porcine labial mucosa shares similarities with human B. mucosa, it is important to recognize the inherent differences between species. Factors such as variations in thickness, permeability, and metabolic activity can affect drug absorption and bioavailability. Additionally, species-specific differences in drug metabolism and receptor distribution should be considered when extrapolating findings to human applications. It is crucial to validate the findings from porcine labial mucosa studies by comparing them with in vivo human studies or other relevant models. Comparative studies can provide further evidence of the translatability of porcine labial mucosa as a model for B. mucosa l drug delivery [2].

Overall, porcine labial mucosa is a reasonable model for B. mucosa l drug delivery research due to its anatomical and physiological similarities to human B. mucosa. It provides a practical and cost-effective means to investigate drug permeation and absorption through the B. mucosa. However, careful interpretation of the results and validation with human studies are necessary to ensure the relevance and applicability of the findings to human drug delivery systems. Porcine labial mucosa refers to the mucous membrane that lines the inner surface of the lips in pigs. It is often used as a model for studying drug permeation and absorption through the B. mucosa, which is the lining of the oral cavity. Here are some key characteristics and considerations regarding porcine labial mucosa. Porcine labial mucosa shares several anatomical and histological similarities with human B. mucosa. It consists of stratified squamous epithelium, connective tissue, blood vessels, and minor salivary glands. The thickness and composition of the epithelial layers are comparable to those of human B. mucosa [3].

Porcine labial mucosa exhibits barrier properties similar to human B. mucosa. It possesses tight junctions between epithelial cells that create a physical barrier to the diffusion of molecules. This barrier function plays a critical role in controlling drug permeation through the mucosa. The permeability of porcine labial mucosa to drugs and other molecules can be assessed to understand their potential for buccal drug delivery. The permeability is influenced by factors such as the physicochemical properties of the drug, the formulation used, and the specific characteristics of the mucosa. Porcine labial mucosa possesses enzymatic activity similar to human B. mucosa. This metabolic activity can influence drug metabolism and bioavailability in the mucosal tissue. Obtaining porcine labial mucosa is relatively accessible, as it can be collected from porcine sources. The large size of the porcine lips allows for easy tissue collection, providing an ample supply for experimentation. The use of porcine labial mucosa offers practicality in terms of availability and cost-effectiveness compared to other experimental models. When utilizing porcine labial mucosa as a model, it is crucial to compare the findings with human studies or other relevant models to ensure the translatability of the results. Comparative studies help validate the use of porcine labial mucosa as a predictive model for drug permeation and absorption in the human B. mucosa [4,5].

Conclusion

The use of porcine labial mucosa, like any animal model, raises ethical considerations. Researchers should adhere to ethical guidelines and obtain appropriate approvals for the use of animal tissues in research. While porcine labial mucosa provides a valuable experimental model for buccal drug delivery research, it is essential to acknowledge the inherent differences between species and consider the limitations associated with the use of animal models. Validation with human studies and careful interpretation of the results are necessary to ensure the relevance and applicability of the findings to human buccal drug delivery systems.

Acknowledgement

None.

Conflict of Interest

No potential conflict of interest was reported by the authors.

References

1. Srivastava, Sonal, Jayant Dewangan, Sakshi Mishra and Aman Divakar, et al. "Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway." Phytomedicine 84 (2021): 153484.

Google Scholar, Crossref, Indexed at

2. Ziegenhagen, Rainer, Katharina Heimberg, Alfonso Lampen and Karen Ildico Hirsch-Ernst. "Safety aspects of the use of isolated Piperine ingested as a bolus." Foods 10 (2021): 2121.

Google Scholar, Crossref, Indexed at

3. Bolat, Zeynep Busra, Zeynep Islek, Bilun Nas Demir and Elif Nur Yilmaz, et al. "Curcumin-and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model." Front Bioeng Biotechnol 8 (2020): 50.

Google Scholar, Crossref, Indexed at

4. Fattah, Abolfazl, Ali Morovati, Zahra Niknam and Ladan Mashouri, et al. "The synergistic combination of cisplatin and piperine induces apoptosis in MCF-7 cell line." Iran J Public Health 50 (2021): 1037.

Google Scholar, Crossref, Indexed at

5. Leal, Mariana Ferreira, José Luiz Martins do Nascimento, Carla Elvira Araújo da Silva and Maria Fernanda Vita Lamarão, et al. "Establishment and conventional cytogenetic characterization of three gastric cancer cell lines." Cancer Genet Cytogenet 195 (2009): 85-91.

Google Scholar, Crossref, Indexed at